E-Liquids from Seven European Countries-Warnings Analysis and Freebase Nicotine Content.
European legislation
e-liquids
nicotine
nicotine form
Journal
Toxics
ISSN: 2305-6304
Titre abrégé: Toxics
Pays: Switzerland
ID NLM: 101639637
Informations de publication
Date de publication:
23 Jan 2022
23 Jan 2022
Historique:
received:
05
12
2021
revised:
04
01
2022
accepted:
17
01
2022
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
25
2
2022
Statut:
epublish
Résumé
Electronic cigarettes are available in a variety of devices with e-liquids also available in many flavors, and nicotine concentrations, albeit less than 20 mg/mL in Europe. Given the dynamics of these products, it is important to evaluate product content, including labeling, nicotine content versus labeled claim, nicotine form, and other aspects that may help policy decisions and align with the Tobacco Product Directive (TPD). Herein, we performed a study on 86 e-liquids from seven European countries (Croatia, Czech Republic, France, Germany, Italy, Poland, and the United Kingdom) with 34 different liquid brands and 57 different flavors. Nicotine content versus labeled claim, labeling, volume, pH, and nicotine form (i.e., freebase nicotine) were evaluated. From all tested products, eight of them from Germany, Poland, and UK (from 3 to 18 mg/mL), met the ±2% criteria. The ±10% criteria was fulfilled by 50 (58.1%) liquids from all countries. Among 71 liquids which contained nicotine, (one e-liquid labeled as 6 mg/mL had no nicotine level quantified), the amount of freebase nicotine differed from 0 to 97.8%, with a mean value 56.5 ± 35.7. None of the tested liquids had nicotine salt listed in the ingredients. Therefore, a low level of freebase nicotine in some liquids was most likely achieved by added flavorings. All tested liquids presented in this study met the basic requirements of the TPD. There were differences in the scope of information about harmfulness, type of warnings on packaging, attaching leaflets, placing graphic symbols, and discrepancies between the declared and quantified nicotine concentrations.
Identifiants
pubmed: 35202238
pii: toxics10020051
doi: 10.3390/toxics10020051
pmc: PMC8875468
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical University of Silesia
ID : PCN-1-002/N/1/F
Références
Tumori. 2014 Jan-Feb;100(1):e24-7
pubmed: 24675506
Tob Control. 2017 Jan;26(1):109-112
pubmed: 26880745
J Anal Methods Chem. 2018 Aug 9;2018:1720375
pubmed: 30159196
Tob Control. 2017 Jul;26(4):440-445
pubmed: 27903958
Food Chem Toxicol. 2008 Jun;46(6):1863-81
pubmed: 18450355
Pediatrics. 2018 Jan;141(1):
pubmed: 29203523
Circulation. 2014 May 13;129(19):1945-52
pubmed: 24821825
Tob Control. 2017 Nov;26(6):709-719
pubmed: 27872344
Expert Opin Drug Deliv. 2021 Jul;18(7):979-989
pubmed: 33576695
Pediatrics. 2018 Apr;141(4):
pubmed: 29507167
Drug Test Anal. 2021 Feb;13(2):242-260
pubmed: 33450135
Toxicol Lett. 2018 May 15;288:143-155
pubmed: 29481849
Curr Environ Health Rep. 2015 Dec;2(4):423-9
pubmed: 26452675
Tob Control. 2016 Nov;25(Suppl 2):ii81-ii87
pubmed: 27633767
Circulation. 2014 May 13;129(19):1972-86
pubmed: 24821826
Sci Rep. 2020 May 13;10(1):7929
pubmed: 32404884
Tob Control. 2016 Apr;25(e1):e10-5
pubmed: 25877377
JAMA Netw Open. 2019 Nov 1;2(11):e1915494
pubmed: 31730180
Drug Alcohol Depend. 2018 Aug 01;189:42-48
pubmed: 29879680
J Allergy Clin Immunol. 2017 Jun;139(6):2013-2014.e1
pubmed: 28087325
Chem Res Toxicol. 2001 Nov;14(11):1465-81
pubmed: 11712903
BMJ. 2014 Nov 26;349:2014.7.0264rep
pubmed: 25428425
Arch Toxicol. 2020 Jun;94(6):1985-1994
pubmed: 32189038
Drug Alcohol Depend. 2017 Sep 1;178:391-398
pubmed: 28704768
Przegl Lek. 2012;69(10):1084-9
pubmed: 23421096
Thorax. 2016 Apr;71(4):376-7
pubmed: 26822067
J Anal Methods Chem. 2020 Mar 10;2020:6178570
pubmed: 32257508
Int J Hyg Environ Health. 2014 Jul;217(6):628-37
pubmed: 24373737
Addiction. 2014 Dec;109(12):2128-34
pubmed: 25196419
Expert Opin Drug Deliv. 2020 Dec;17(12):1727-1736
pubmed: 32842785
J Addict Med. 2020 Dec;14(6):443-445
pubmed: 32097237
Tob Control. 2020 Sep;29(5):531-536
pubmed: 31519795
Nicotine Tob Res. 2012 Oct;14(10):1127-39
pubmed: 22377934